Venezuela uses distressed bonds to settle debts with drugmakers
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- First Financial to acquire Hickory Point Bank in $111.3M deal
- McKesson reports cybersecurity incident affecting its information systems
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
Jefferies Cuts Price Target on Pfizer (PFE) to $42; Reiterates Buy
March 8, 2016 8:41 AM ESTJefferies maintained a Buy rating on Pfizer (NYSE: PFE), and cut the price target to $42.00 (from $45.00). Jefferies updated their model following the Form S-4 filing for certain LOE assumptions, as well as some fine-tuning on stand-alone operating costs and tax rate assumptions in the... More
